Tetrahydro-4h-Pyran-4-One
Description:
It is an intermediate for Entrectinib and Tazemetostat. Entrectinib is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors.
Tazemetostat, is a medication used for the treatment of adults and adolescents aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. It may help keep the cancer cells from growing.
Looking for similar products? Visit Product Comparison Guide
We also manufacture the following intermediates:
Product Detail
- CAS Number： 29943-42-8
- Molecular Formula：C5H8O2
- Molecular Weight： 100.12
- Synonyms: 4-Oxotetrahydropyranoxan-4-one; Dihydro-2h-pyran-4(3H)-one
| Name of The Material | CAS NO. |
|---|---|
| 2,2,6,6-Tetramethylpieperidine | 768-66-1 |
| Methyl-2-(4-Nitrophenyl)Acetate | 2945-08-6 |
| 3,5-Difluorobenzyl Bromide | 141776-91-2 |
DOCUMENTATION
An ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and GMP Certified Company
Application
Entrectinib is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors.